At-Home Light-Emitting Diode Devices Safe, Effective for Acne Treatment
By Lori Solomon HealthDay Reporter
THURSDAY, March 6, 2025 -- At-home light-emitting diode (LED) devices are effective for treating acne, according to a research letter published online March 5 in JAMA Dermatology.
Sherry Ershadi and John S. Barbieri, M.D., from Brigham and Women’s Hospital in Boston, conducted a systematic review and meta-analysis to synthesize the available data regarding the safety and efficacy of at-home LED devices in the treatment of mild-to-moderate acne.
Based on data from six studies (216 participants; age range, 12 to 50 years), the researchers found that compared with control, the LED devices resulted in greater percent change in inflammatory lesions (45.3 percent; I2 = 43.2 percent; five studies), noninflammatory lesions (47.7 percent; I2 = 83.22 percent; four studies), and the Investigator Global Assessment (45.7 percent; I2 = 54.85 percent; four studies). Red, blue, and combination wavelength devices were all effective. Benefit was typically seen after four to 12 weeks of use. There were no severe adverse reactions reported; however, a small number of patients did report mild dryness, erythema, or discomfort or pain during light therapy.
"At-home LED devices, particularly those that combine red and blue light, are efficacious for acne and can likely complement other over-the-counter and prescription treatments," the authors write.
Barbieri disclosed ties to Honeydew Care, Dexcel Pharma, and Sanofi Pasteur.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Benzoyl Peroxide Formulation Characteristics Explain Variation in Benzene Levels
WEDNESDAY, Feb. 19, 2025 -- Formulation characteristics can explain much of the observed variation in benzene levels of over-the-counter benzoyl peroxide-containing products...
FDA Approves Emrosi for Rosacea in Adults
TUESDAY, Nov. 12, 2024 -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults. The...
Benzene Exposure Results From Benzoyl Peroxide Drug Product Use
FRIDAY, Oct. 11, 2024 -- Potential benzene exposure occurs as a result of benzoyl peroxide (BPO) drug product use, according to a study published online Oct. 7 in the Journal of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.